AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
5.24
+0.42 (8.71%)
At close: May 8, 2026, 4:00 PM EDT
5.49
+0.25 (4.77%)
After-hours: May 8, 2026, 7:59 PM EDT
AbCellera Biologics Employees
AbCellera Biologics had 562 employees as of December 31, 2025. The number of employees decreased by 34 or -5.70% compared to the previous year.
Employees
562
Change (1Y)
-34
Growth (1Y)
-5.70%
Revenue / Employee
$133,680
Profits / Employee
-$260,520
Market Cap
1.60B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 562 | -34 | -5.70% |
| Dec 31, 2024 | 596 | 10 | 1.71% |
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Sep 30, 2023 | 630 | 155 | 32.63% |
| Jun 30, 2023 | 590 | 140 | 31.11% |
| Mar 31, 2023 | 525 | 125 | 31.25% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Sep 30, 2022 | 475 | 115 | 31.94% |
| Jun 30, 2022 | 450 | 148 | 49.01% |
| Mar 31, 2022 | 400 | 194 | 94.17% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Sep 30, 2021 | 360 | 186 | 106.90% |
| Jun 30, 2021 | 302 | 128 | 73.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 711 |
| Agios Pharmaceuticals | 540 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 307 |
ABCL News
- 2 days ago - AbCellera to Present at Upcoming Investor Conferences in May and June 2026 - Business Wire
- 5 days ago - AbCellera initiated with an Overweight at Cantor Fitzgerald - TheFly
- 18 days ago - AbCellera Biologics Transcript: 2026 Bloom Burton & Co. Healthcare Investor Conference - Transcripts
- 19 days ago - AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call - Business Wire
- 4 weeks ago - AbCellera initiated with a Buy at JonesResearch - TheFly
- 5 weeks ago - AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 - Business Wire
- 7 weeks ago - AbCellera Biologics Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 2 months ago - AbCellera Biologics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts